HPV Test Developers Warned on Vaccine Impact in New Guidance

Companies developing diagnostics for human papillomavirus (HPV) should be alert for the impact of HPV vaccines on the potential test subject population, the FDA says in a new guidance.
Devices & Diagnostics Letter